Urology

Category

Spero Therapeutics Announces Positive Results from Phase 3 ADAPT-PO Trial of Oral Tebipenem HBr in Complicated Urinary Tract Infection and Acute Pyelonephritis

Spero Therapeutics announced positive topline results from ADAPT-PO, a pivotal Phase 3 clinical trial evaluating Spero’s oral antibiotic candidate, tebipenem HBr, for the treatment of adults with complicated urinary tract infection (cUTI) and acute pyelonephritis...

Society of Urologic Oncology Trials Consortium (SUO-CTC) Represents Over 200 Urology Investigative Sites

The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC), created, owed and operated by its members, represents a clinical research investigator network over 400 members and more than 200 clinical research sites in the United States and Canada. This...